Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Pluri Inc.

Biological Products, (No Diagnostic Substances) · Haifa

  1. PrincipalsLiat ZaltsChief Financial OfficerYaky YanayChief Executive Officerand 5 more
  2. CompanyPluri Inc.Haifa
  3. Phone line+972 74 710 8600General business
Request a quotepluri-biotech.com ↗

Pluri Inc. is an SEC-registered Nasdaq-listed company (ticker PLUR) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 7

Chief executive

Yaky YanayChief Executive Officer

Chair & board

Eitan AjchenbaumDirector (Board)
Maital Shemesh-RasmussenDirector (Board)
Rami Avraham LeviDirector (Board)

Finance

Liat ZaltsChief Financial Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Alexandre Weinstein Manieu — Director (Board)

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Liat Zalts — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Eitan Ajchenbaum — Director (Board)

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Yaky Yanay — Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers